SUBCATEGORY FEED

Merck Acquires Cidara Therapeutics for Potential Flu Prevention | Novo Nordisk and Pfizer Engage in Bidding War Over Metsera | Novartis to Acquire Avidity Biosciences for $12 Billion | Merck Acquires Cidara Therapeutics for Potential Flu Prevention | Novo Nordisk and Pfizer Engage in Bidding War Over Metsera | Novartis to Acquire Avidity Biosciences for $12 Billion

Business / Biotech and Pharma

Merck Acquires Cidara Therapeutics for Potential Flu Prevention

Merck is set to acquire Cidara Therapeutics in a $9.2 billion deal, gaining access to Cidara's experimental antiviral drug, CD388, aimed at universal flu prevention. This move is part of Merck's strategy to diversify its revenue streams as...

Image via CNBC

Nov 14, 2025 13:02 Merck bets on flu prevention with about $9.2 billion deal for Cidara Therapeutics

Business / Biotech and Pharma

Novo Nordisk and Pfizer Engage in Bidding War Over Metsera

Oct 30, 2025 11:32 Novo Nordisk hijacks Pfizer with bid for U.S. biotech Metsera

Business / Biotech and Pharma

Novartis to Acquire Avidity Biosciences for $12 Billion

Oct 27, 2025 12:04 Novartis to buy U.S. biotech firm Avidity Biosciences for about $12 billion in cash

Retail Finance Economy Media Energy Trade Legal Markets Automotive International Trade